000 01613 a2200409 4500
005 20250515013506.0
264 0 _c20060824
008 200608s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s00280-005-0184-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFandy, Tamer E
245 0 0 _aTrichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cOct 2006
300 _a471-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntifungal Agents
_xpharmacology
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aApoptosis Regulatory Proteins
_xpharmacology
650 0 4 _aCaspase 8
650 0 4 _aCaspases
_xdrug effects
650 0 4 _aDNA Primers
_xgenetics
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xpharmacology
650 0 4 _aMembrane Glycoproteins
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xdrug effects
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Necrosis Factor-alpha
_xpharmacology
700 1 _aSrivastava, Rakesh K
773 0 _tCancer chemotherapy and pharmacology
_gvol. 58
_gno. 4
_gp. 471-7
856 4 0 _uhttps://doi.org/10.1007/s00280-005-0184-3
_zAvailable from publisher's website
999 _c16049848
_d16049848